5-Butan-2-ylsulfanyl-3-(4-chlorophenyl)-4-cyanothiophene-2-carboxylic acid | 882281-87-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 噻吩类
• 英文名称: 5-Butan-2-ylsulfanyl-3-(4-chlorophenyl)-4-cyanothiophene-2-carboxylic acid
• CAS: 882281-87-0
• 化学式: C₁₆H₁₄ClNO₂S₂
• 分子量: 351.878
• InChiKey: IZXSEAJSPXOFLR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.6
• 重原子数：
  22
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  115
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  5-Butan-2-ylsulfanyl-3-(4-chlorophenyl)-4-cyanothiophene-2-carboxylic acid 、 L-谷氨酰胺叔丁酯 在 N-甲基吗啉 、 1-羟基苯并三唑 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下， 以 二氯甲烷 为溶剂， 生成 methyl (2S)-(5-(sec-butylthio)-3-(4-chlorophenyl)-4-cyanothiophene-2-carboxamido)-4-(methylthio)butanoate
  参考文献：
  名称：

  在3-芳基噻吩上引入甲硫氨酸模拟物：对蛋白质法呢基转移酶抑制和抗寄生虫活性的影响†

  摘要：

  在我们寻找具有抗寄生虫活性的新的蛋白质法呢基转移酶抑制剂的过程中，我们发现在3-芳基噻吩的2位添加甲硫氨酸残基可以大大改善酶的抑制作用。为了研究此蛋氨酸残基对FTase和抗寄生虫活性的影响，研究了29个新型的四取代噻吩蛋氨酸或类似的部分被合成。对人和布鲁氏锥虫蛋白法呢基转移酶以及4种原生动物寄生虫的增殖评估了这些新衍生物：恶性疟原虫，布鲁氏锥虫，克鲁氏锥虫和利什曼原虫。一些化合物在T.b上显示出有希望的低微摩尔或亚微摩尔活性。Brucei和L. donovani证实了这一新类别作为抗寄生虫药的潜力。

  DOI：

  10.1039/c3md00065f

文献信息

• INHIBITION OF ISOPRENOID BIOSYNTHETIC PATHWAYS TO TREAT NEUROINFLAMMATORY DISORDERS
  申请人：TABACZYNSKI David A.

  公开号：US20160303146A1

  公开（公告）日：2016-10-20

  This invention provides methods and pharmaceutical compositions that can treat neuroinflammatory disease by reducing the production of pyrophosphate intermediates produced during the biosynthesis of isoprenoids. The pyrophosphate compounds being inhibited are normally produced through the mevalonate and non-mevalonate pathways of the host vertebrate organisms and their symbiotic and pathogenic microorganisms. The methods involve administering to a patient an inhibitor of the mevalonate-dependent pathway, an inhibitor of the non-mevalonate pathway, or combination of such inhibitors.
• INHIBITION OF ISOPRENOID BIOSYNTHETIC PATHWAYS TO TREAT AUTOIMMUNE DISORDERS
  申请人：TABACZYNSKI David A.

  公开号：US20160375041A1

  公开（公告）日：2016-12-29

  The invention provides methods and pharmaceutical compositions that can treat autoimmune disease by reducing the production of pyrophosphate intermediates produced during the biosynthesis of isoprenoids. The pyrophosphate compounds being inhibited are normally produced through the mevalonate and non-mevalonate pathways of the host vertebrate organisms and their symbiotic and pathogenic microorganisms. The methods involve administering to a patient an inhibitor of the mevalonate-dependent pathway, an inhibitor of the non-mevalonate pathway, or combination of such inhibitors.
• Introduction of methionine mimics on 3-arylthiophene: influence on protein farnesyltransferase inhibition and on antiparasitic activity
  作者：Damien Bosc、Elisabeth Mouray、Philippe Grellier、Sandrine Cojean、Philippe M. Loiseau、Joëlle Dubois

  DOI：10.1039/c3md00065f

  日期：——

  new protein farnesyltransferase inhibitors with antiparasitic activity, we found that addition of a methionine residue at position 2 of 3-arylthiophenes greatly improved enzyme inhibition. To investigate the influence of this methionine residue on FTase and antiparasitic activities, 29 novel tetrasubstituted thiophenes bearing methionine or analogous moieties were synthesised. These new derivatives were

  在我们寻找具有抗寄生虫活性的新的蛋白质法呢基转移酶抑制剂的过程中，我们发现在3-芳基噻吩的2位添加甲硫氨酸残基可以大大改善酶的抑制作用。为了研究此蛋氨酸残基对FTase和抗寄生虫活性的影响，研究了29个新型的四取代噻吩蛋氨酸或类似的部分被合成。对人和布鲁氏锥虫蛋白法呢基转移酶以及4种原生动物寄生虫的增殖评估了这些新衍生物：恶性疟原虫，布鲁氏锥虫，克鲁氏锥虫和利什曼原虫。一些化合物在T.b上显示出有希望的低微摩尔或亚微摩尔活性。Brucei和L. donovani证实了这一新类别作为抗寄生虫药的潜力。